Illumina Inc (ILMN)
451.81
-0.33 -0.07%
NASDAQ
Jun 15, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 3.473B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 4.28 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 630.00M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 69.90% |
| Profit Margin (Quarterly) | 13.45% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 65.96B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 19.22 |
| PE Ratio | 105.56 |
| Price to Book Value | 13.40 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.4388 |
| Free Cash Flow (Quarterly) | 240.00M |
| Return on Equity | Upgrade |
View All ILMN News
News
-
WireHeadlineTime (ET)
-
Yahoo06/12 06:10
-
Yahoo06/10 08:00
-
Yahoo06/10 06:43
-
Yahoo06/09 09:08
-
Yahoo06/09 06:47
-
SA Breaking News06/04 13:50
-
Yahoo06/04 12:55
-
Yahoo06/04 09:09
-
Yahoo06/04 08:37
-
SA Breaking News06/01 13:02
-
Yahoo06/01 07:40
-
MT Newswires06/01 07:04
-
Yahoo06/01 03:05
-
Yahoo05/31 20:00
-
Yahoo05/31 16:00
-
Yahoo05/31 10:45
-
Yahoo05/31 07:24
-
Yahoo05/29 07:07
-
Yahoo05/29 06:45
-
Yahoo05/28 13:27
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/06/2021 17:00 EST | Earnings Calls | Q2 2021 Earnings Call |
| 04/27/2021 | Earnings Results | Q1 2021 Earnings Results |
| 04/27/2021 17:00 EST | Earnings Calls | Q1 2021 Earnings Call |
| 02/11/2021 | Earnings Results | Q4 2020 Earnings Results |
| 02/11/2021 17:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 10/29/2020 | Earnings Results | Q3 2020 Earnings Results |
| 10/29/2020 17:00 EST | Earnings Calls | Q3 2020 Earnings Call |
| 08/06/2020 17:00 EST | Earnings Calls | Q2 2020 Earnings Call |
| 08/06/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
- URL: https://www.illumina.com
- Investor Relations URL: https://investor.illumina.com
- HQ State/Province: California
- Sector: Healthcare
- Industry: Diagnostics & Research
- Equity Style: Large Cap/Growth
- Next Earnings Release: Aug. 06, 2021
- Last Earnings Release: Apr. 27, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 451.81 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| EGFFX | Edgewood Growth Retail | 5.80% |
| IBB | iShares Nasdaq Biotechnology ETF | 5.20% |
| EDOC | Global X Telemedicine & Digital Hlth ETF | 4.77% |
| HQH | Tekla Healthcare Investors | 4.48% |
| FBT | First Trust NYSE Arca Biotech ETF | 3.50% |
| VWIGX | Vanguard International Growth Inv | 2.80% |
| LGRCX | Loomis Sayles Growth C | 2.18% |
| POLRX | Polen Growth Investor | 2.13% |
| XLV | Health Care Select Sector SPDR® ETF | 1.41% |
| VWUSX | Vanguard US Growth Investor | 1.17% |
| VHCIX | Vanguard Health Care Index Admiral | 1.02% |
| VHT | Vanguard Health Care ETF | 1.02% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ILMN Tweets Stocktwits
Advertisement
